Aripiprazole versus chlorpromazine for people with schizophrenia and schizophrenia-like psychoses

To evaluate the effects of aripiprazole compared with chlorpromazine for people with schizophrenia and schizophrenia-like psychoses.

This is a protocol.

Health topics:

Mental health > Schizophrenia & psychosis > Antipsychotic medication: atypical

Mental health > Schizophrenia & psychosis > Antipsychotic medication: other

Published:

5 February 2016

Authors:

Bhattacharjee J, El-Sayeh HG

Was this helpful? Donate.

If you found this evidence helpful, please consider donating to Cochrane. We are a charity that produces accessible evidence to help people make health and care decisions.
Donate
Print
PDF
Citation
Bhattacharjee J, El-Sayeh HG. Aripiprazole versus chlorpromazine for people with schizophrenia and schizophrenia-like psychoses. Cochrane Database of Systematic Reviews 2016, Issue 2. Art. No.: CD012072. DOI: 10.1002/14651858.CD012072